Ivermectin:: A positive allosteric effector of the α7 neuronal nicotinic acetylcholine receptor

被引:252
作者
Krause, RM
Buisson, B
Bertrand, S
Corringer, PJ
Galzi, JL
Changeux, JP
Bertrand, D [1 ]
机构
[1] Univ Geneva, Ctr Med, Dept Physiol, CH-1211 Geneva 4, Switzerland
[2] Inst Pasteur, URA CNRS D1284, F-75724 Paris 15, France
关键词
D O I
10.1124/mol.53.2.283
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
We report that preapplication of ivermectin, in the micromolar range, strongly enhances the subsequent acetylcholine-evoked current of the neuronal chick or human alpha 7 nicotinic acetylcholine receptors reconstituted in Xenopus laevis oocytes and K-28 cells. This potentiation does not result from nonspecific Cl- currents. The concomitant increase in apparent affinity and cooperativity of the dose-response curve suggest that ivermectin acts as a positive allosteric effector. This interpretation is supported by the observation of an increase in efficiency of a partial agonist associated with the potentiation and by the differential effect of ivermectin on mutants within the M2 channel domain. Ivermectin effects reveal a novel allosteric site for pharmacological agents on neuronal alpha 7 nicotinic acetylcholine receptors.
引用
收藏
页码:283 / 294
页数:12
相关论文
共 40 条
[1]   PHARMACOLOGICAL PROPERTIES OF THE HOMOMERIC ALPHA-7 RECEPTOR [J].
BERTRAND, D ;
BERTRAND, S ;
BALLIVET, M .
NEUROSCIENCE LETTERS, 1992, 146 (01) :87-90
[2]   STEROIDS INHIBIT NICOTINIC ACETYLCHOLINE-RECEPTORS [J].
BERTRAND, D ;
VALERA, S ;
BERTRAND, S ;
BALLIVET, M ;
RUNGGER, D .
NEUROREPORT, 1991, 2 (05) :277-280
[3]   MUTATIONS AT 2 DISTINCT SITES WITHIN THE CHANNEL DOMAIN M2 ALTER CALCIUM PERMEABILITY OF NEURONAL ALPHA-7 NICOTINIC RECEPTOR [J].
BERTRAND, D ;
GALZI, JL ;
DEVILLERSTHIERY, A ;
BERTRAND, S ;
CHANGEUX, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (15) :6971-6975
[4]   Electrophysiology: A method to investigate the functional properties of ligand-gated channels [J].
Bertrand, D ;
Buisson, B ;
Krause, RM ;
Hu, HY ;
Bertrand, S .
JOURNAL OF RECEPTOR AND SIGNAL TRANSDUCTION RESEARCH, 1997, 17 (1-3) :227-242
[5]   NICOTINIC RECEPTOR - AN ALLOSTERIC PROTEIN SPECIALIZED FOR INTERCELLULAR COMMUNICATION [J].
BERTRAND, D ;
CHANGEUX, JP .
SEMINARS IN NEUROSCIENCE, 1995, 7 (02) :75-90
[6]  
Bertrand D, 1991, METHODS NEUROSCIENCE, V4, P174
[7]   Paradoxical allosteric effects of competitive inhibitors on neuronal alpha 7 nicotinic receptor mutants [J].
Bertrand, S ;
DevillersThiery, A ;
Palma, E ;
Buisson, B ;
Edelstein, SJ ;
Corringer, PJ ;
Changeux, JP ;
Bertrand, D .
NEUROREPORT, 1997, 8 (16) :3591-3596
[8]  
BUISSON B, 1998, COMP ENDOCRINOLOGY
[9]   AVERMECTINS, NEW FAMILY OF POTENT ANTHELMINTIC AGENTS - PRODUCING ORGANISM AND FERMENTATION [J].
BURG, RW ;
MILLER, BM ;
BAKER, EE ;
BIRNBAUM, J ;
CURRIE, SA ;
HARTMAN, R ;
KONG, YL ;
MONAGHAN, RL ;
OLSON, G ;
PUTTER, I ;
TUNAC, JB ;
WALLICK, H ;
STAPLEY, EO ;
OIWA, R ;
OMURA, S .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1979, 15 (03) :361-367
[10]  
Campbell WC, 1989, IVERMECTIN ABAMECTIN